long term use of glp 1 GLP-1 Companion Health Pack Daily Packets GLP-1 Therapy Weight Loss Medication

doi:10.1016/j.arthro.2015.06.038 (8) Hernigou P, Flouzat Lachaniette CH, Delambre J, et al

Footnotes Publishers note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations

We recommend labeling the vial with the date of reconstitution

Conclusions The results of this large population-based cohort study indicate that in patients with NAFLD and type 2 diabetes, GLP-1RAs and SGLT2 inhibitors are associated with lower incidences of macrovascular diseases and all-cause mortality compared with other glucose-lowering drugs

doi: 10.1016/j.fbp.2017.04.003 58 SahneFMohammadiMNajafpourGDMoghadamniaAA

If a dose is missed, do not double the next dose